Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  New England Journal of Medicine

• Publication date

  2005-03-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMOA042831PMID 15800227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RAPAMYCIN PROTECTS ALLOGRAFTS FROM REJECTION WHILE SIMULTANEOUSLY ATTACKING TUMORS IN IMMUNOSUPPRESSED MICE

  2004cited by this paper
• Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

  2004cited by this paper
• Malignancy in renal transplantation.

  2004cited by this paper
• Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor.

  2004cited by this paper
• Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.

  2004cited by this paper
• Mammalian target of rapamycin inhibition as therapy for hematologic malignancies

  2004cited by this paper
• The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

  2004cited by this paper
• Mammalian target of rapamycin inhibition as therapy for hematologic malignancies

  2004cited by this paper
• Initiation of angiogenic Kaposi's sarcoma lesions.

  2003cited by this paper
• Rapamycin is an effective inhibitor of human renal cancer metastasis.

  2003cited by this paper
• Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

  2002cited by this paper
• Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy1

  2002cited by this paper
• Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.

  2001cited by this paper
• Expression of vascular endothelial growth factor and its receptors Flt-1 and KDR/Flk-1 in chronic cyclosporine nephrotoxicity.

  2001cited by this paper
• New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

  1999cited by this paper
• Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma.

  1999cited by this paper
• Cyclosporine induces cancer progression by a cell-autonomous mechanism

  1999cited by this paper
• Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi’s Sarcoma Cells*

  1999cited by this paper
• Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway

  1998cited by this paper
• Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.

  1997cited by this paper
• Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence.

  1996cited by this paper
• Cancers in cyclosporine-treated vs azathioprine-treated patients.

  1996cited by this paper
• Sarcomas in organ allograft recipients.

  1995cited by this paper
• Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper

• HHV-8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions.

  2026cites this paper
• The PI3K/Akt Pathway in Herpesvirus Biology: A Double-Edged Sword in Host-Virus Interactions.

  2026cites this paper
• Single-cell and spatial transcriptomics reveal mTOR-driven cellular fate of spindle cells and immune evasion in classic Kaposi's sarcoma.

  2026cites this paper
• Enfermedad de Kaposi

  2026cites this paper
• Post-transplant Kaposi Sarcoma with Kaposi Sarcoma Inflammatory Cytokine Syndrome: A Case Report with Literature Review

  2026cites this paper
• Incidence, screening, and management of de novo malignancies in liver transplant patients: A review

  2025cites this paper
• mTOR blockade mitigates chemotherapy drug-induced intestinal toxicity via inhibition of pyroptosis.

  2025cites this paper
• A Case of Cutaneous Kaposi Sarcoma in a Patient Post–Heart Transplantation

  2025cites this paper
• Prognostic Factors and Long-Term Survival in Kaposi’s Sarcoma Patients: Results from a 28-Year Retrospective Cohort

  2025cites this paper
• Updates on Kaposi Sarcoma.

  2025cites this paper
• Kaposi sarcoma of a liver graft in living donor liver transplantation: a rare case report

  2025cites this paper
• Analyzing research trends in the relationship between immunosuppressants and cancer following organ transplantation: a bibliometric study from 2001 to 2023

  2025cites this paper
• Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunity

  2025cites this paper
• Novel association between graft rejection and post-transplant malignancy in solid organ transplantation

  2025cites this paper
• Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case report

  2025cites this paper
• Modern Approach to Manage Patients With Kaposi Sarcoma

  2025cites this paper
• Risk Factors for the Development of Malignancies Post-Transplantation in Kidney Transplant Recipients

  2025cites this paper
• Maladie de Kaposi

  2025cites this paper
• Immune profiling in solid organ transplant recipients with HHV-8 infection: Identification of immunological biomarkers for KICS and Kaposi's sarcoma.

  2025cites this paper
• Oncological Complications of Liver Transplantation: A Narrative Review on De Novo and Donor-Transmitted Cancers

  2025cites this paper
• Kaposi Sarcoma Involving Kidney Allografts: A Report of Two Cases From Qatar and Literature Review

  2024cites this paper
• Kaposi Sarcoma in Two Lung Transplant Recipients: A Single-Center Experience.

  2024cites this paper
• Targeting hypoxia-inducible factors in malignancies caused by Kaposis sarcoma associated herpesvirus.

  2024cites this paper
• Comparison of the effect of Everolimus, Prednisolone, and a combination of both on experimentally induced peritoneal adhesions in rats

  2024cites this paper
• Kaposi’s Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series

  2024cites this paper
• Rapamycin immunomodulation utilizes time-dependent alterations of lymph node architecture, leukocyte trafficking, and gut microbiome

  2024cites this paper
• Viral Load Measurements for Kaposi Sarcoma Herpesvirus (KSHV/HHV8): Review and an Updated Assay

  2024cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024cites this paper
• Approach to Late Noninfectious Post-Transplant Complications.

  2024cites this paper
• Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting

  2024cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• De Novo Kaposi Sarcoma in an HIV-Negative Liver Transplant Recipient With Ulcerative Colitis and Primary Sclerosing Cholangitis

  2024cites this paper
• Serologic screening and molecular surveillance of Kaposi sarcoma herpesvirus (KSHV)/human herpesvirus-8 (HHV-8) infections for early recognition and effective treatment of KSHV-associated inflammatory cytokine syndrome (KICS) in solid organ transplant recipients.

  2024cites this paper
• A Bibliometric Analysis of the Most Cited Journal Articles in Kidney Transplantation

  2023cites this paper
• Athena: Specialty Certificate Examination case for Cutaneous Oncology.

  2023cites this paper
• Hypoxia and hypoxia‐inducible factors in Kaposi sarcoma‐associated herpesvirus infection and disease pathogenesis

  2023cites this paper
• Cutaneous Oncology in the Immunosuppressed.

  2023cites this paper
• Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies

  2023cites this paper
• Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?

  2023cites this paper
• Non-HIV Kaposi Sarcoma in an Immunocompetent Patient with High-Risk Behavior: Elucidating Subtypes and Risk Factors for Diagnosis

  2023cites this paper
• Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation

  2023cites this paper
• Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center

  2023cites this paper
• Evolving challenges with long‐term care of liver transplant recipients

  2023cites this paper
• Transplant-associated Kaposi’s sarcoma in a kidney allograft: a case report

  2023cites this paper
• Inhibition of the Mechanistic Targets of Rapamycin Beyond Transplant Immunosuppression: A Mini-Review

  2023cites this paper
• Onco-Pathogen Mediated Cancer Progression and Associated Signaling Pathways in Cancer Development

  2023cites this paper
• Oral–visceral iatrogenic Kaposi sarcoma following treatment for acute lymphoblastic leukemia: a case report and review of the literature

  2022cites this paper
• Transplant Onconephrology in Patients With Kidney Transplants.

  2022cites this paper
• The ORF45 Protein of Kaposi’s Sarcoma-Associated Herpesvirus and Its Critical Role in the Viral Life Cycle

  2022cites this paper
• Sarcoma de Kaposi en orofaringe en paciente postrasplante renal y manejo con inhibidor de señal de coestimulación e inhibidor de mTOR

  2022cites this paper
• Multicentric Castleman's disease in kidney transplant: A case report and literature review.

  2022cites this paper
• Kaposi Sarcoma with Mucocutaneous Involvement in French Guiana: An Epidemiological Study between 1969 and 2019

  2022cites this paper
• Anasarca, and Lymphadenopathy in a Kidney Transplant Patient: A Diagnostic and Therapeutic Challenge

  2022cites this paper
• Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.

  2022cites this paper
• Current Knowledge of Immunosuppression as a Risk Factor for Skin Cancer Development.

  2022cites this paper
• Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients

  2022cites this paper
• Response to "Comments on sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients" (SOTRs).

  2022cites this paper
• Personalized immunosuppression after kidney transplantation

  2022cites this paper
• Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma

  2022cites this paper
• Mechanistic Target of Rapamycin (mTOR) Inhibitors.

  2022cites this paper
• Current Status of Malignant Tumors after Organ Transplantation

  2022cites this paper
• Immunohistochemical and molecular studies of resolved cutaneous Kaposi sarcoma in a kidney transplant recipient: A clinicopathological observation.

  2022cites this paper
• Pegylated Liposomal Doxorubicin and Kidney-Limited Thrombotic Microangiopathy in a Kidney Transplant Recipient: A Case Report

  2022cites this paper
• Kaposi's Sarcoma‐associated Herpesvirus—Antiviral Treatment

  2021cites this paper
• Renal Diseases

  2021cites this paper
• De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference.

  2021cites this paper
• Survival of Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation in Patients under Rapamycin Treatment

  2021cites this paper
• Predicted Cure and Survival Among Transplant Recipients With a Previous Cancer Diagnosis

  2021cites this paper
• Viral infections in lung transplantation

  2021cites this paper
• Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection

  2021cites this paper
• Cancers associated with human gammaherpesviruses

  2021cites this paper
• Spotlight on ocular Kaposi’s sarcoma: an update on the presentation, diagnosis, and management options

  2021cites this paper
• Trends in Kaposi’s Sarcoma Morbidity: A Retrospective Cohort Study of Heart and Lung Transplant Recipients

  2021cites this paper
• Systematic review of sirolimus in dermatological conditions

  2021cites this paper
• Rapamycin promotes autophagy cell death of Kaposi’s sarcoma cells through P75NTR activation

  2021cites this paper
• Diagnosis and treatment of classic and iatrogenic Kaposi's sarcoma: Italian recommendations

  2021cites this paper
• Advances in the Study of Kaposi’s Sarcoma in Human

  2021cites this paper
• Petroselinum crispum, a commonly consumed food, affects sirolimus level in a renal transplant recipient: a case report

  2021cites this paper
• Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report

  2021cites this paper
• Donor‐derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report

  2021cites this paper
• Sarcoma de Kaposi ganglionar postrasplante renal: reporte de dos casos en un centro de trasplante colombiano

  2021cites this paper
• Cutaneous Head and Neck Cancers in the High-Risk Immunosuppressed Population.

  2021cites this paper
• Rapamycin Inhibitors for Eye Squamous Cell Carcinoma after Renal Transplantation: A Case Report

  2021cites this paper
• Malignancies in renal transplant recipients: A retrospective single-center descriptive study

  2021cites this paper
• [Successful treatment with paclitaxel of a visceral relapse of post-transplant Kaposi's sarcoma].

  2021cites this paper
• Kaposi’s sarcoma herpesvirus activates the hypoxia response to usurp HIF2α-dependent translation initiation for replication and oncogenesis

  2021cites this paper
• Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer

  2021cites this paper
• 3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells

  2021cites this paper
• A viral protein utilizes the NDP 52 / CALCOCO 2 selective autophagy receptor to disassemble processing bodies

  2021cites this paper
• Common Soft Tissue Tumors

  2021cites this paper
• De novo and recurrent malignancy.

  2020cites this paper
• Successful treatment of pediatric post-liver transplant Kaposi`s sarcoma with paclitaxel.

  2020cites this paper
• ДЛИТЕЛЬНАЯ ТЕРАПИЯ САРКОМЫ КАПОШИ С ПРИМЕНЕНИЕМ ПРОСПИДИЯ ХЛОРИДА И ИНГИБИТОРОВ MTOR-РЕЦЕПТОРОВ У ПАЦИЕНТА В ОТДАЛЕННОМ ПЕРИОДЕ ПОСЛЕ ТРАНСПЛАНТАЦИИ ПОЧКИ

  2020cites this paper
• The previously common post-kidney transplant Kaposi sarcoma has become non-existent for a decade: an Egyptian experience

  2020cites this paper
• Understanding rare infections post-lung transplantation

  2020cites this paper
• Italian guidelines for the diagnosis and treatment of classic and iatrogenic Kaposi's sarcoma.

  2020cites this paper
• A Primer on a Comprehensive Genetic Approach to Vascular Anomalies

  2020cites this paper
• KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi’s sarcoma

  2020cites this paper
• Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study

  2020cites this paper
• Infiltrating Kaposi sarcoma presenting as acute kidney injury: An unexpected consequence of deliberate hepatitis C–positive organ transplantation

  2020cites this paper